ArticleInternational journal of clinical pharmacy2013
Non-medical prescribers and pharmacovigilance: participation, competence and future needs.
Article in International journal of clinical pharmacy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Factors Associated with Underreporting of Adverse Drug Reactions by Health Care Professionals: A Systematic Review Update.Drug safety · 2023Pooled it
- Nurses' Knowledge, Attitudes, and Practice in Relation to Pharmacovigilance and Adverse Drug Reaction Reporting: A Systematic Review.BioMed research international · 2021Pooled it
- Risks Associated with the Use of Intranasal Corticosteroids: An Analysis of Adverse Reactions Reported to EudraVigilance.Healthcare (Basel, Switzerland) · 2024Article
- South African physiotherapists' attitudes to medicine prescription as an extension of practice.The South African journal of physiotherapy · 2023Article
- Challenges to the consolidation of pharmacovigilance practices in Brazil: limitations of the hospital pharmacist.Therapeutic advances in drug safety · 2020Article
- Review
- Nonmedical prescriber experiences of training and competence to report adverse drug reactions in the UK.Journal of clinical pharmacy and therapeutics · 2019Article
- Awareness and compliance with pharmacovigilance requirements amongst UK oncology healthcare professionals.Ecancermedicalscience · 2018Article
- Nonmedical prescribing: where are we now?Therapeutic advances in drug safety · 2016Review
- Implementation of independent nurse prescribing in UK mental health settings: focus on attention-deficit/hyperactivity disorder.Attention deficit and hyperactivity disorders · 2014Review
- Pharmacists in pharmacovigilance: can increased diagnostic opportunity in community settings translate to better vigilance?Drug safety · 2014Review
- Preaching to the converted - optimising adverse drug reaction reporting by dentists.British dental journal · 2014Article
- Impact of a Policy Change on Pharmacists' Reporting of Adverse Drug Reactions.The Canadian journal of hospital pharmacyArticle
- A Comparative Safety Analysis of Medicines Based on the UK Pharmacovigilance and General Practice Prescribing Data in England.In vivo (Athens, Greece)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo determine UK non-medical prescribers' (NMPs) (supplementary or independent) current participation and self-reported competence in pharmacovigilance, and their perceptions of training and future needs.
settingNon-medical prescribers in health care in the United Kingdom. Awareness of and participation in the Yellow Card Scheme (YCS); attitudes towards ADR reporting; strategies to encourage reporting; pharmacovigilance training; and demographics. The sample comprised nurse (n = 912) and pharmacist (n = 2,439) NMPs in the UK.
main outcome measuresSelf-reported competence in pharmacovigilance, knowledge of and participation in the YCS, attitudes towards ADR reporting; strategies to encourage ADR reporting; pharmacovigilance training during NMP training.
resultsSix hundred and thirteen responses were received giving an overall response rate of 20.4 %. Response rates for nurse and pharmacist prescribers were 32.2 % (n = 293) and 13.1 % (n = 320) respectively. Three hundred and fifty-nine respondents (58.6 %) had submitted a Yellow Card. Although the majority of respondents (70.4 %) felt competent in pharmacovigilance, a third (34.2 %) said they needed further training. Respondents reported a positive attitude towards ADR reporting, yet only a minority (22.9 %) correctly answered factual questions about the YCS. Approximately a third of respondents (35.6 %) "couldn't remember" if pharmacovigilance was covered in their prescribing training. Publicity and education were commonly suggested measures to enhance contribution to the YCS.
conclusionWhile NMPs report participation and competence in ADR reporting, there are several key issues to consider including the need for further training and support to optimise their role in pharmacovigilance.
Indexed as
Identifiers
23277419What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.